Medication Guide

Read the Medication Guide that comes with Adalimumab-bwwd before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your doctor about your medical condition or treatment.

•

are being treated for an infection.

•

get a lot of infections or have infections that keep coming back.

•

have diabetes.

•

have TB, or have been in close contact with someone with TB.

•

were born in, lived in, or traveled to countries where there is more risk for getting TB. Ask your doctor if you are not sure.

•

live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, or blastomycosis). These infections may happen or become more severe if you use Adalimumab-bwwd. Ask your doctor if you do not know if you have lived in an area where these infections are common.

•

have or have had hepatitis B.

•

use the medicine ORENCIA (abatacept), KINERET (anakinra), RITUXAN (rituximab), IMURAN (azathioprine), or PURINETHOL (6–mercaptopurine, 6-MP).

•

are scheduled to have major surgery.

After starting Adalimumab-bwwd, call your doctor right away if you have an infection, or any sign of an infection.

Adalimumab-bwwd can make you more likely to get infections or make any infection that you may have worse.

Cancer

•

For children and adults taking Tumor Necrosis Factor (TNF)-blockers, including Adalimumab-bwwd, the chances of getting cancer may increase.

•

There have been cases of unusual cancers in children, teenagers, and young adults using TNF-blockers.

•

People with rheumatoid arthritis (RA), especially more serious RA, may have a higher chance for getting a kind of cancer called lymphoma.

•

If you use TNF blockers including Adalimumab-bwwd, your chance of getting two types of skin cancer may increase (basal cell cancer and squamous cell cancer of the skin). These types of cancer are generally not life-threatening if treated. Tell your doctor if you have a bump or open sore that does not heal.

•

Some people receiving TNF blockers including Adalimumab-bwwd developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. Most of these people were male teenagers or young men. Also, most people were being treated for Crohn’s disease or ulcerative colitis with another medicine called IMURAN® (azathioprine) or PURINETHOL® (6-mercaptopurine, 6–MP).

What is Adalimumab-bwwd?

Adalimumab-bwwd is a medicine called a Tumor Necrosis Factor (TNF) blocker. Adalimumab-bwwd is used:

•

to reduce the signs and symptoms of:

o

moderate to severe rheumatoid arthritis (RA) in adults. Adalimumab-bwwd can be used alone, with methotrexate, or with certain other medicines.

o

moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. Adalimumab-bwwd can be used alone, or with methotrexate.

o

psoriatic arthritis (PsA) in adults. Adalimumab-bwwd can be used alone or with certain other medicines.

o

ankylosing spondylitis (AS) in adults.

o

moderate to severe hidradenitis suppurativa (HS) in adults.

•

to treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.

•

to treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.

•

to treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

•

to treat non-infectious intermediate, posterior, and panuveitis in adults

What should I tell my doctor before taking Adalimumab-bwwd?

Adalimumab-bwwd may not be right for you. Before starting Adalimumab-bwwd, tell your doctor about all of your medical conditions, including if you:

•

have an infection. See “What is the most important information I should know about Adalimumab-bwwd?”

•

have or have had cancer.

•

have any numbness or tingling or have a disease that affects your nervous system such as multiple sclerosis or Guillain-Barré syndrome.

•

have or had heart failure.

•

have recently received or are scheduled to receive a vaccine. You may receive vaccines, except for live vaccines while using Adalimumab-bwwd. Children should be brought up to date with all vaccines before starting Adalimumab-bwwd.

•

are allergic to Adalimumab-bwwd or to any of its ingredients. See the end of this Medication Guide for a list of ingredients in Adalimumab-bwwd.

•

are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. You and your doctor should decide if you should take Adalimumab-bwwd while you are pregnant or breastfeeding.

•

have a baby and you were using Adalimumab-bwwd during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially tell your doctor if you use:

•

ORENCIA (abatacept), KINERET (anakinra), REMICADE (infliximab), ENBREL (etanercept), CIMZIA (certolizumab pegol) or SIMPONI (golimumab), because you should not use Adalimumab-bwwd while you are also using one of these medicines.

•

RITUXAN (rituximab). Your doctor may not want to give you Adalimumab-bwwd if you have received RITUXAN (rituximab) recently.

•

IMURAN (azathioprine) or PURINETHOL (6–mercaptopurine, 6-MP).

Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine.

How should I take Adalimumab-bwwd?

•

Adalimumab-bwwd is given by an injection under the skin. Your doctor will tell you how often to take an injection of Adalimumab-bwwd. This is based on your condition to be treated. Do not inject Adalimumab-bwwd more often than you were prescribed.

•

See the Instructions for Use inside the carton for complete instructions for the right way to prepare and inject Adalimumab-bwwd.

•

Make sure you have been shown how to inject Adalimumab-bwwd before you do it yourself. You can call your doctor or 1-833-267-3070 if you have any questions about giving yourself an injection. Someone you know can also help you with your injection after they have been shown how to prepare and inject Adalimumab-bwwd.

•

Do not try to inject Adalimumab-bwwd yourself until you have been shown the right way to give the injections. If your doctor decides that you or a caregiver may be able to give your injections of Adalimumab-bwwd at home, you should receive training on the right way to prepare and inject Adalimumab-bwwd.

•

Do not miss any doses of Adalimumab-bwwd unless your doctor says it is okay. If you forget to take Adalimumab-bwwd, inject a dose as soon as you remember. Then, take your next dose at your regular scheduled time. This will put you back on schedule. In case you are not sure when to inject Adalimumab-bwwd, call your doctor or pharmacist.

•

If you take more Adalimumab-bwwd than you were told to take, call your doctor.

•

Psoriasis. Some people using adalimumab products had new psoriasis or worsening of psoriasis they already had. Tell your doctor if you develop red scaly patches or raised bumps that are filled with pus. Your doctor may decide to stop your treatment with Adalimumab-bwwd.

Call your doctor or get medical care right away if you develop any of the above symptoms. Your treatment with Adalimumab-bwwd may be stopped.

The most common side effects of Adalimumab-bwwd include:

•

injection site reactions: redness, rash, swelling, itching, or bruising. These symptoms usually will go away within a few days. Call your doctor right away if you have pain, redness or swelling around the injection site that does not go away within a few days or gets worse.

•

upper respiratory infections (including sinus infections)

•

headaches

•

rash

These are not all the possible side effects with Adalimumab-bwwd. Tell your doctor if you have any side effect that bothers you or that does not go away. Ask your doctor or pharmacist for more information.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

How should I store Adalimumab-bwwd?

•

Store Adalimumab-bwwd in the refrigerator at 36ºF to 46ºF (2ºC to 8ºC). Store Adalimumab-bwwd in the original carton until use to protect it from light.

•

Do not freeze Adalimumab-bwwd. Do not use Adalimumab-bwwd if frozen, even if it has been thawed.

•

Refrigerated Adalimumab-bwwd may be used until the expiration date printed on the Adalimumab-bwwd carton, autoinjector or prefilled syringe. Do not use Adalimumab-bwwd after the expiration date.

•

If needed, for example when you are traveling, you may also store Adalimumab-bwwd autoinjector or prefilled syringe at room temperature up to 77°F (25°C) for up to 14 days. Store Adalimumab-bwwd autoinjector or prefilled syringe in the original carton until use to protect it from light.

•

Throw away Adalimumab-bwwd autoinjector or prefilled syringe if it has been kept at room temperature and not been used within 14 days.

•

Record the date you first remove Adalimumab-bwwd autoinjector or prefilled syringe from the refrigerator in the spaces provided on the carton.

•

Do not store Adalimumab-bwwd in extreme heat or cold.

•

The solution should be clear and colorless to pale brown. Do not use an autoinjector or prefilled syringe if the liquid is cloudy, discolored, or has flakes or particles in it.

•

Do not drop or crush Adalimumab-bwwd. The prefilled syringe is glass.

Keep Adalimumab-bwwd, injection supplies, and all other medicines out of the reach of children.

General information about the safe and effective use of Adalimumab-bwwd

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Adalimumab-bwwd for a condition for which it was not prescribed. Do not give Adalimumab-bwwd to other people, even if they have the same condition. It may harm them.

This Medication Guide summarizes the most important information about Adalimumab-bwwd. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about Adalimumab-bwwd that is written for health professionals. For more information call Cordavis Limited at 1-833-267-3070.